Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Harmony Biosciences Holdings Inc (HRMY)
Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,722,017
  • Shares Outstanding, K 58,572
  • Annual Sales, $ 437,860 K
  • Annual Income, $ 181,470 K
  • 60-Month Beta 0.55
  • Price/Sales 3.89
  • Price/Cash Flow 8.20
  • Price/Book 3.50
Trade HRMY with:

Options Overview Details

View History
  • Implied Volatility 53.06% ( -3.43%)
  • Historical Volatility 65.84%
  • IV Percentile 24%
  • IV Rank 24.50%
  • IV High 99.87% on 03/28/23
  • IV Low 37.87% on 08/10/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 198
  • Volume Avg (30-Day) 88
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 4,293
  • Open Int (30-Day) 4,384

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.73
  • Number of Estimates 4
  • High Estimate 0.79
  • Low Estimate 0.66
  • Prior Year 1.01
  • Growth Rate Est. (year over year) -27.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.00 +34.68%
on 10/31/23
30.43 -2.64%
on 11/29/23
+9.92 (+50.33%)
since 10/30/23
3-Month
18.61 +59.21%
on 10/13/23
39.26 -24.54%
on 09/13/23
-5.71 (-16.16%)
since 08/30/23
52-Week
18.61 +59.21%
on 10/13/23
62.08 -52.28%
on 12/05/22
-28.26 (-48.82%)
since 11/28/22

Most Recent Stories

More News
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 3.74 (+1.17%)
CARA : 0.9651 (+0.69%)
CRBP : 4.81 (-0.82%)
HRMY : 29.58 (+0.61%)
JAZZ : 114.19 (-0.06%)
Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript

HRMY earnings call for the period ending September 30, 2023.

HRMY : 29.58 (+0.61%)
HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL RESULTS ON OCTOBER 31, 2023

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

HRMY : 29.58 (+0.61%)
Wells Fargo, JPMorgan Chase rise; Harmony Biosciences, Belden fall, Friday, 10/13/2023

Stocks that traded heavily or had substantial price changes on Friday: Wells Fargo, JPMorgan Chase rise; Harmony Biosciences, Belden fall

WFC : 44.19 (+0.94%)
HRMY : 29.58 (+0.61%)
C : 45.96 (+0.46%)
CMTL : 11.85 (-0.50%)
DG : 129.26 (+0.29%)
UNH : 545.29 (+1.93%)
JPM : 155.11 (+0.51%)
Why Shares of Harmony Bioscience Are Falling on Friday

The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.

ZYNE : 1.3000 (+2.36%)
HRMY : 29.58 (+0.61%)
HARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3 INTUNE STUDY EVALUATING PITOLISANT IN PATIENTS WITH IDIOPATHIC HYPERSOMNIA

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

HRMY : 29.58 (+0.61%)
HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

HRMY : 29.58 (+0.61%)
2 Magnificent Growth Stocks to Buy Right Now

These two biotech stocks could be big winners for patient investors.

MRK : 100.89 (-0.24%)
PFE : 30.12 (+0.13%)
NVO : 101.37 (-0.62%)
GOOG : 135.15 (-0.92%)
DNA : 1.3950 (+0.36%)
HRMY : 29.58 (+0.61%)
HARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D., NAMED TO 2023 PHARMAVOICE 100 LIST OF TOP INDUSTRY LEADERS

/PRNewswire/ -- Jeffrey M. Dayno, M.D., President & CEO of Harmony Biosciences, was named to the 2023 PharmaVoice 100 list for his unwavering commitment to...

HRMY : 29.58 (+0.61%)
HARMONY BIOSCIENCES TO PARTICIPATE IN 2023 CANTOR GLOBAL HEALTHCARE CONFERENCE

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

HRMY : 29.58 (+0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.

See More

Key Turning Points

3rd Resistance Point 31.24
2nd Resistance Point 30.84
1st Resistance Point 30.12
Last Price 29.58
1st Support Level 28.99
2nd Support Level 28.59
3rd Support Level 27.87

See More

52-Week High 62.08
Fibonacci 61.8% 45.48
Fibonacci 50% 40.35
Fibonacci 38.2% 35.22
Last Price 29.58
52-Week Low 18.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar